You are here

2022 IDF Research Grant

IDF has a seed grant program to encourage and support patient-oriented research on primary immunodeficiencies (PI). The intent of the grant is to support well-defined research projects that have a specified benefit for improving the treatment, health, disease management or diagnosis of people with PI. The program is open to applicants currently based in the U.S. and will consist of one-year grants. Award Value: $25,000 - $50,000 (a somewhat higher level of support is available for a few exceptional proposals).
The grant submission deadline has passed. Awardees will be announced in April 2022.  Thank you to all those who applied.

White Paper Challenge

IDF is sponsoring a White Paper Challenge and invites submissions to address: innovative practices to expand awareness in communities of color, methods to increase equity in clinical trials, or novel approaches to shortening the time between diagnosis and treatment. The challenge goes out to all individuals, institutions, schools, and researchers. Three different awards of $10,000 will be announced by the end of April 2022. 

The grant submission deadline has passed. Awardees will be announced in April 2022.  Thank you to all those who applied.